AR030275A1 - Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirla - Google Patents
Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirlaInfo
- Publication number
- AR030275A1 AR030275A1 ARP010101368A ARP010101368A AR030275A1 AR 030275 A1 AR030275 A1 AR 030275A1 AR P010101368 A ARP010101368 A AR P010101368A AR P010101368 A ARP010101368 A AR P010101368A AR 030275 A1 AR030275 A1 AR 030275A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- heterocyclic
- oxo
- aryl
- hydroxyl
- Prior art date
Links
- 230000006907 apoptotic process Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002131 composite material Substances 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004043 oxo group Chemical group O=* 0.000 abstract 3
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000004104 aryloxy group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19175500P | 2000-03-24 | 2000-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030275A1 true AR030275A1 (es) | 2003-08-20 |
Family
ID=22706808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010101368A AR030275A1 (es) | 2000-03-24 | 2001-03-23 | Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirla |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7129272B2 (enExample) |
| EP (1) | EP1267882B1 (enExample) |
| JP (1) | JP2003527430A (enExample) |
| KR (1) | KR100788226B1 (enExample) |
| CN (1) | CN1443070A (enExample) |
| AR (1) | AR030275A1 (enExample) |
| AT (1) | ATE428429T1 (enExample) |
| AU (2) | AU2001239551B8 (enExample) |
| CA (1) | CA2403086C (enExample) |
| DE (1) | DE60138371D1 (enExample) |
| NZ (1) | NZ521464A (enExample) |
| TW (1) | TWI284535B (enExample) |
| WO (1) | WO2001070233A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1420794B1 (en) | 2001-08-31 | 2017-12-27 | Sucampo AG | Prostaglandin analogs as chloride channel openers |
| CN1605336A (zh) | 2003-10-10 | 2005-04-13 | 中国医学科学院药物研究所 | 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用 |
| BRPI0607084A2 (pt) * | 2005-01-27 | 2009-08-04 | Sucampo Ag | uso de um composto 11-desóxiprostaglandina, composição compreendendo o mesmo, e composto |
| KR101396731B1 (ko) * | 2005-03-31 | 2014-05-19 | 산텐 세이야꾸 가부시키가이샤 | 프로스타글란딘 Ｆ２ａ 유도체를 유효 성분으로서 함유하는망막신경세포 보호제 |
| EP1870099A4 (en) | 2005-04-13 | 2008-07-16 | Ube Industries | PROTECTION AGAINST RETINAL NERVOUS CELLS WITH INDAZOLE DERIVATIVE AS ACTIVE SUBSTANCE |
| EP1803809A3 (en) * | 2005-08-12 | 2007-12-19 | Abgenomics Corporation | Modulation of peroxisome proliferator-activated receptors |
| US8871752B2 (en) | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
| KR101628415B1 (ko) * | 2008-09-04 | 2016-06-08 | 산텐 세이야꾸 가부시키가이샤 | 15,15-디플루오로프로스타글란딘 Ｆ2α 유도체를 유효 성분으로서 함유하는 모발 성장 촉진제 |
| US9084815B2 (en) | 2009-09-16 | 2015-07-21 | Sucampo Ag | Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor |
| WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
| CA1322749C (en) | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
| US5221763A (en) | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
| ES2052735T3 (es) * | 1987-09-18 | 1994-07-16 | R Tech Ueno Ltd | Un metodo para producir un agente hipotensor ocular. |
| CA2030345C (en) * | 1989-11-22 | 1998-12-08 | Ryuji Ueno | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
| JPH0761944B2 (ja) * | 1989-11-22 | 1995-07-05 | 株式会社アールテック・ウエノ | 脳機能改善処置剤 |
| TW249226B (enExample) | 1990-04-04 | 1995-06-11 | Aderk Ueno Kk | |
| CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
| JP3625946B2 (ja) * | 1995-03-10 | 2005-03-02 | 株式会社アールテック・ウエノ | 視神経障害改善剤 |
| JPH08277222A (ja) * | 1995-04-05 | 1996-10-22 | Green Cross Corp:The | 神経疾患の予防治療剤 |
| JP3964060B2 (ja) * | 1997-10-21 | 2007-08-22 | 独立行政法人科学技術振興機構 | アポトーシス抑制剤 |
| US6087395A (en) | 1997-10-21 | 2000-07-11 | Japan Science And Technology Corporation | Isocarbacyclin derivatives as apoptosis inhibitors |
| JP2000169394A (ja) * | 1998-12-04 | 2000-06-20 | Yoshitomi Pharmaceut Ind Ltd | アポトーシス誘導剤 |
-
2001
- 2001-03-23 NZ NZ521464A patent/NZ521464A/en not_active IP Right Cessation
- 2001-03-23 CN CN01809737A patent/CN1443070A/zh active Pending
- 2001-03-23 WO PCT/JP2001/002307 patent/WO2001070233A2/en not_active Ceased
- 2001-03-23 EP EP01914192A patent/EP1267882B1/en not_active Expired - Lifetime
- 2001-03-23 CA CA2403086A patent/CA2403086C/en not_active Expired - Fee Related
- 2001-03-23 AR ARP010101368A patent/AR030275A1/es unknown
- 2001-03-23 TW TW090107002A patent/TWI284535B/zh not_active IP Right Cessation
- 2001-03-23 KR KR1020027012410A patent/KR100788226B1/ko not_active Expired - Fee Related
- 2001-03-23 AT AT01914192T patent/ATE428429T1/de not_active IP Right Cessation
- 2001-03-23 AU AU2001239551A patent/AU2001239551B8/en not_active Ceased
- 2001-03-23 AU AU3955101A patent/AU3955101A/xx active Pending
- 2001-03-23 DE DE60138371T patent/DE60138371D1/de not_active Expired - Lifetime
- 2001-03-23 JP JP2001568431A patent/JP2003527430A/ja active Pending
- 2001-03-26 US US09/816,655 patent/US7129272B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2403086A1 (en) | 2001-09-27 |
| CN1443070A (zh) | 2003-09-17 |
| JP2003527430A (ja) | 2003-09-16 |
| WO2001070233A2 (en) | 2001-09-27 |
| NZ521464A (en) | 2004-09-24 |
| ATE428429T1 (de) | 2009-05-15 |
| AU2001239551B2 (en) | 2005-07-21 |
| WO2001070233A3 (en) | 2002-06-13 |
| TWI284535B (en) | 2007-08-01 |
| KR100788226B1 (ko) | 2007-12-26 |
| AU2001239551B8 (en) | 2005-11-24 |
| US20020025985A1 (en) | 2002-02-28 |
| KR20020081474A (ko) | 2002-10-26 |
| DE60138371D1 (de) | 2009-05-28 |
| EP1267882B1 (en) | 2009-04-15 |
| EP1267882A2 (en) | 2003-01-02 |
| US7129272B2 (en) | 2006-10-31 |
| CA2403086C (en) | 2010-08-17 |
| AU3955101A (en) | 2001-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR100696A2 (es) | Uso de un compuesto de 15-ceto-prostaglandina para fabricar una composición para tratar estreñimiento inducido por drogas | |
| AR036391A1 (es) | Uso de un compuesto de prostaglandina para preparar una composicion farmaceutica para abrir los canales de cic en un mamifero y compuestos de prostaglandina | |
| AR030275A1 (es) | Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirla | |
| ES2104072T3 (es) | Redistribucion de composiciones de policarbonato organico. | |
| HN1998000155A (es) | Medicamentos | |
| ES2175350T3 (es) | Compuestos triciclicos que tienen afinidad de union a receptores de melatonina, su produccion y uso. | |
| CO5700742A2 (es) | Moduladores del receptor de quimioquina ccr5 | |
| CL2024000581A1 (es) | Compuestos de 6-aminopirazolopirimidina y su uso médico. | |
| AR032465A1 (es) | Derivados anticonvulsivos utiles para la preparacion de un medicamento para prevenir el desarrollo de la diabetes mellitus de tipo ii y del sindrome x | |
| ES2149215T3 (es) | Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p. | |
| AR029381A1 (es) | Composicion para tratamiento de los desordenes de secrecion externa, metodo que la emplea y uso de un derivado de acido graso para prepararla | |
| CO4700455A1 (es) | Derivados tetraciclicos y proceso para su preparacion | |
| PE20221341A1 (es) | Derivados de piridazin-3(2h)-ona fusionados con azol | |
| AR034737A1 (es) | Conjunto de elementos de desgaste | |
| PA8620501A1 (es) | Compuestos utiles en terapia | |
| AR056980A1 (es) | Derivados de dihidrobenzofurano, composiciones farmaceuticas, y uso de los mismos | |
| AR042670A1 (es) | Uso del abridor del canal de cloruro para preparar un compuesto farmaceutico para tratar el malestar abdominal | |
| AR110149A2 (es) | Composición catártica | |
| AR036044A1 (es) | Compuestos piranoindazoles, composiciones farmaceuticas y su uso para la manufactura de un medicamento para el tratamiento del glaucoma | |
| BR0114701A (pt) | Combinação de fenofibrato e coenzima q 10 para tratamento de disfunção endotelial | |
| CL2004000366A1 (es) | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. | |
| ES2070238T3 (es) | Emulsion de lipidos que contiene un analogo de prostaglandina. | |
| AR030277A1 (es) | Composicion promotora de la secrecion biliar y uso de 15-ceto-prostaglandina para producirla | |
| DOP2005000035A (es) | Nuevos derivados de bencil (ideno)- lactamas | |
| AR055846A1 (es) | Compuesto de prostaglandina y metodo para tratar trastornos del sistema nervioso central |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |